CCIA
Campbell & Co Investment Adviser’s Integra LifeSciences IART Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $632K | Buy |
+51,490
| New | +$632K | 0.04% | 705 |
|
2025
Q1 | – | Sell |
-55,840
| Closed | -$1.27M | – | 1159 |
|
2024
Q4 | $1.27M | Buy |
+55,840
| New | +$1.27M | 0.1% | 306 |
|
2024
Q3 | – | Sell |
-13,577
| Closed | -$396K | – | 1203 |
|
2024
Q2 | $396K | Sell |
13,577
-10,236
| -43% | -$298K | 0.03% | 737 |
|
2024
Q1 | $844K | Sell |
23,813
-11,880
| -33% | -$421K | 0.07% | 472 |
|
2023
Q4 | $1.55M | Buy |
+35,693
| New | +$1.55M | 0.14% | 220 |
|
2023
Q3 | – | Sell |
-10,999
| Closed | -$452K | – | 1062 |
|
2023
Q2 | $452K | Sell |
10,999
-21,833
| -66% | -$898K | 0.08% | 485 |
|
2023
Q1 | $1.88M | Buy |
+32,832
| New | +$1.88M | 0.35% | 29 |
|
2022
Q4 | – | Sell |
-15,604
| Closed | -$661K | – | 877 |
|
2022
Q3 | $661K | Buy |
+15,604
| New | +$661K | 0.15% | 227 |
|
2022
Q2 | – | Sell |
-4,069
| Closed | -$261K | – | 786 |
|
2022
Q1 | $261K | Sell |
4,069
-950
| -19% | -$60.9K | 0.07% | 525 |
|
2021
Q4 | $336K | Sell |
5,019
-100
| -2% | -$6.7K | 0.12% | 316 |
|
2021
Q3 | $351K | Buy |
5,119
+450
| +10% | +$30.9K | 0.11% | 321 |
|
2021
Q2 | $319K | Buy |
+4,669
| New | +$319K | 0.13% | 303 |
|
2019
Q1 | – | Sell |
-5,767
| Closed | -$288K | – | 554 |
|
2018
Q4 | $288K | Buy |
5,767
+132
| +2% | +$6.59K | 0.28% | 166 |
|
2018
Q3 | $371K | Buy |
+5,635
| New | +$371K | 0.25% | 140 |
|
2015
Q4 | – | Sell |
-5,200
| Closed | -$310K | – | 146 |
|
2015
Q3 | $310K | Buy |
+5,200
| New | +$310K | 0.21% | 180 |
|